NovaGray Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $31.2M

  • Investors
  • 7

NovaGray General Information

Description

Developer of companion diagnostic tests intended to improve radiation therapy planning. The company's biomarker-based tests assess patients' sensitivity for personalizing radiotherapy using a single blood sample, enabling physicians to personalize standard treatments to patients' sensitivity in order to improve outcomes and reduce complication costs as well as treatment costs.

Contact Information

Website
www.nova-gray.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Espace Entreprises
  • 199 rue Helene Boucher, Castelnau-le-Lez
  • 34170 Montpellier
  • France
+33 04
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Espace Entreprises
  • 199 rue Helene Boucher, Castelnau-le-Lez
  • 34170 Montpellier
  • France
+33 04

NovaGray Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NovaGray Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC 28-Feb-2025 $31.2M Completed Generating Revenue
9. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
8. Angel (individual) 08-Apr-2020 Completed Generating Revenue
7. Grant 23-Mar-2018 Completed Startup
6. Accelerator/Incubator 01-Jun-2017 Completed Startup
5. Grant 22-Mar-2017 Completed Startup
4. Angel (individual) 03-Feb-2017 Cancelled Startup
3. Angel (individual) 24-Jun-2016 Completed Startup
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator 01-Jan-2016 Completed Startup
To view NovaGray’s complete valuation and funding history, request access »

NovaGray Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary Shares
Ordinary Shares
To view NovaGray’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

NovaGray Patents

  • 24

    Total Documents Applications and Grants

  • Total Patents Families

  • 13

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

NovaGray Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020230421-A1 In vitro method for assessing the risk of prostate side effect after treatment by ionizing radiation Inactive 06-Mar-2019
CA-3131979-A1 In vitro method for assessing the risk of prostate side effect after treatment by ionizing radiation Pending 06-Mar-2019
EP-3705891-A1 In vitro method for assessing the risk of prostate side effect after treatment by ionizing radiation Pending 06-Mar-2019
EP-3935384-A1 In vitro method for assessing the risk of prostate side effect after treatment by ionizing radiation Inactive 06-Mar-2019
US-20220157462-A1 In vitro method for assessing the risk of prostate side effect after treatment by ionizing radiation Inactive 06-Mar-2019 G16H50/30
To view NovaGray’s complete patent history, request access »

NovaGray Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NovaGray Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Boost Invest MedVallée Accelerator/Incubator
Angel (individual) Minority
Horizon 2020 Government
MedTech Innovator Accelerator/Incubator Minority
National Cancer Institute Government
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

NovaGray FAQs

  • When was NovaGray founded?

    NovaGray was founded in 2015.

  • Where is NovaGray headquartered?

    NovaGray is headquartered in Montpellier, France.

  • What is the size of NovaGray?

    NovaGray has 6 total employees.

  • What industry is NovaGray in?

    NovaGray’s primary industry is Diagnostic Equipment.

  • Is NovaGray a private or public company?

    NovaGray is a Private company.

  • What is NovaGray’s current revenue?

    The current revenue for NovaGray is .

  • How much funding has NovaGray raised over time?

    NovaGray has raised $33.2M.

  • Who are NovaGray’s investors?

    Boost Invest MedVallée, , Horizon 2020, MedTech Innovator, and National Cancer Institute are 5 of 7 investors who have invested in NovaGray.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process